JENNIFER MADDOX: Open Payments
NPI 1780069393 · WILLIAMSTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,692 in 95 payments from 23 companies in 2025. Trend: 2023 $1,831 · 2024 $1,755 · 2025 $1,692
Food & beverage: $1,692
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $320 |
| ABBVIE INC. | 18 | $286 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $128 |
| Vanda Pharmaceuticals Inc. | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| PFIZER INC. | 4 | $64 |
| Lilly USA, LLC | 3 | $57 |
Products named: VRAYLAR, XIFAXAN, Ozempic, HETLIOZ, Wegovy, TRINTELLIX, JARDIANCE, REXULTI.
Industry payments across KY — which companies pay providers there.
